MJH Life Sciences Acquires BPD Healthcare

WindRose Health Investors Makes Strategic Investment in BPD

August 3, 2022

Marketing & Advertising

WindRose Health Investors, a New York-based healthcare private equity firm, has completed a strategic recapitalization investment in BPD, a Boca Raton-based provider of data-driven marketing services for hospitals and health systems. The founders and management team will continue to lead and remain significant shareholders as WindRose supports BPD's expansion of service offerings and accelerated growth.

MJH Life Sciences Acquires Mesmerize Media from The Beekman Group

February 15, 2023

Media & Entertainment

MJH Life Sciences has acquired Mesmerize Media, a point-of-care healthcare media and patient-education platform, from an affiliate of The Beekman Group (Beekman Investment Partners II, LP). Under Beekman's ownership Mesmerize transformed from an out-of-home advertising business into a leading healthcare media platform; MJH will integrate Mesmerize's point-of-care and OOH capabilities into its portfolio to expand its healthcare media and marketing offerings.

Galanthus Partners Acquires BPD Zenith

August 3, 2021

Cloud & SaaS

Galanthus Partners, an investment partnership, has acquired UK-based BPD Zenith, a global enterprise asset management cloud provider and IBM Maximo partner. The acquisition is intended to allow BPD Zenith to invest in its team and product roadmap to support continued organic and inorganic growth and further develop its cloud-based asset management and predictive analytics offerings.

BD Acquires Edwards Lifesciences' Critical Care Product Group

September 3, 2024

Medical Devices

BD (Becton, Dickinson and Company) completed the acquisition of Edwards Lifesciences' Critical Care product group and has renamed the business BD Advanced Patient Monitoring, based in Irvine, California. The deal expands BD's smart connected care portfolio with advanced monitoring technologies and AI-enabled clinical decision tools, and aligns the new unit within BD's Medical segment to enable integration with BD's infusion platforms and future closed-loop monitoring innovations.

PhaseWell Research Acquires Bio Behavioral Health

January 21, 2026

Healthcare Services

PhaseWell Research, a national clinical research site company, announced that Bio Behavioral Health has joined its network to expand access to neuropsychiatric and CNS clinical trials. The deal strengthens PhaseWell's community-based research capabilities and broadens patient access to complex clinical studies across its growing national footprint.

Danforth Advisors Acquires BW Health Group

May 29, 2024

Healthcare Services

Danforth Advisors has acquired BW Health Group, a commercialization and product-launch services platform serving small- and mid-sized life science companies. The deal adds commercial readiness, launch planning and biopharma marketing capabilities (Benchworks and BW Consulting) to Danforth's integrated life-science advisory and operational services offering.